http://archive.fast-edgar.com/20240319/A622M22MC222U2Z2222Q22OZL3DDR2Q22262
Filed on: March 19, 2024
http://archive.fast-edgar.com/20240319/AL2ZB62CLM22CZ52222Q2ZY2FU2DZ222Y662
Filed on: March 19, 2024
http://archive.fast-edgar.com/20240319/AA22MG2CZZ2RSZZ222ZJ2ZYNJNQCEZ223266
Filed on: March 19, 2024
JPMorgan Chase Financial Company LLC Structured Investments
$1,853,000
Auto Callable Contingent Interest Notes Linked to the Common Stock of Intel Corporation due March 19, 2026
Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.
·The notes are designed for investors who seek a Contingent Interest Payment with respect to each Review Date for... (continue reading...)As filed with the Securities and Exchange Commission on March 19, 2024
Registration No. 333-216931
333-223511
333-230024
333-236473
333-253080
333-262759
333-266489
333-269688
333-276907
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO 1.
TO:
FORM S-8 REGISTRATION STATEMENT (File No. 333-216931)
FORM S-8 REGISTRATION STATEMENT (File No. 333-223511)
FORM S-8 REGISTRATION STATEMENT (File... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K Enliven Therapeutics, For: Mar 19
-
Form 424B2 CITIGROUP INC
-
Form 4 Cerence Inc. For: Mar 18 Filed by: Tempesta Daniel David
-
Form 8-K Intra-Cellular Therapies For: Mar 14
-
Form 8-K Alteryx, Inc. For: Mar 19
-
Form 424B5 Cobrew SA/NV Filed by: ANHEUSER-BUSCH COMPANIES, LLC
-
Form 424B5 CNH Industrial Capital Filed by: New Holland Credit Company, LLC
-
Form D/A DVC Fund 9, LP
-
Form 6-K HUYA Inc. For: Mar 19
-
Form 8-K EYENOVIA, INC. For: Mar 19
-
Form 424B3 PUBLIC SERVICE CO OF
-
Form 425 Nocturne Acquisition Filed by: Nocturne Acquisition Corp
-
Form 4 Grindr Inc. For: Mar 16 Filed by: Zage George Raymond III
-
Form 8-K Nocturne Acquisition For: Mar 19
-
Form 4 Grindr Inc. For: Mar 16 Filed by: Lu James Fu Bin
-
Form 6-K VICINITY MOTOR CORP For: Mar 19
-
Form 6-K IceCure Medical Ltd. For: Mar 19
-
Form 13F-HR M3 Advisory Group, LLC For: Dec 31
-
Form SC TO-C PureTech Health plc Filed by: PureTech Health plc
-
Form 6-K JOYY Inc. For: Mar 19
-
Form 10-K LIXTE BIOTECHNOLOGY HOLD For: Dec 31
-
Form 8-K R1 RCM Inc. /DE For: Mar 18
-
Form 8-K Cocrystal Pharma, Inc. For: Mar 19
-
Form 8-K ARCH RESOURCES, INC. For: Mar 19
-
Form 6-K PureTech Health plc For: Mar 19
-
Form 8-K KULR Technology Group, For: Mar 19
-
Form 4 FTC Solar, Inc. For: Mar 18 Filed by: Chatila Ahmad R
-
Form 6-K Maris Tech Ltd. For: Mar 19
-
Form 424B5 Athene Holding Ltd.
-
Form 10-K Coya Therapeutics, Inc. For: Dec 31
-
Form D/A CoastEdge Focus Fund
-
Form 8-K COLUMBUS MCKINNON CORP For: Mar 18
-
Form 4 CEVA INC For: Mar 15 Filed by: SILVER LOUIS
-
Form 8-K Coya Therapeutics, Inc. For: Mar 19
-
Form D SoraFinance a Series of
-
Form 6-K Evaxion Biotech A/S For: Mar 19
-
Form 424B5 UNITEDHEALTH GROUP INC
-
Form D OPX2024 AI 03 a Series
-
Form 4 Chubb Ltd For: Mar 15 Filed by: Wayland Joseph F
-
Form D Nesh a Series of CGF2021
-
Form 6-K dLocal Ltd For: Mar 19
-
Form 8-K MICROSTRATEGY Inc For: Mar 19
-
Form D Tundra Angels Upwardli
-
Form 10-K Aterian, Inc. For: Dec 31
-
Form ARS S&P Global Inc. For: Dec 31
-
Form 144 PARK OHIO HOLDINGS CORP Filed by: WERT JAMES W
-
Form 8-K Crescent Energy Co For: Mar 19
-
Form DEFA14A Floor & Decor Holdings,
-
Form SC 13D/A Bally's Corp Filed by: Standard General L.P.